Top compounds associated with response to ALS2


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC 0.085 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
mRNA VX-680 GDSC1000 pan-cancer AAC 0.083 0.1
mRNA bendamustine CTRPv2 pan-cancer AAC -0.059 0.1
mRNA 5-FU CTRPv2 pan-cancer AAC -0.053 0.1
mRNA CIL55A CTRPv2 pan-cancer AAC 0.079 0.1
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.059 0.1
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.083 0.1
mRNA PD-0325901 CCLE pan-cancer AAC 0.066 0.1
Download CSV